Abstract:Background: Islet cell transplantation can improve islet function, but the source is lack. Bone marrow mesenchymal stem cells (BMSCs) can be induced to differentiate into islet cells, and have strong tissue repair ability in diabetes foot, diabetic cardiomyopathy and diabetic neuropathy. Objective: To investigate BMSC survival and turnover and improvement in blood glucose and renal lesions in model rats of type 2 diabetes following BMSC transplantation. Design, time and setting: The cytology in vivo study was performed at the Department of Biochemistry and Molecular Biology, Shanxi Medical University from February to July 2008. Materials: Male Wistar rats were provided by Animal Experimental Center, Shanxi Medical University. Streptozotocin (Sigma, USA) was used for this study. Methods: BMSCs were isolated from rat (4-week old) bone marrow in vitro, adhered and purified. At the third passage, BrdU-labeled BMSCs were used for transplantation. A total of 60 rats were randomly assigned into 3 groups. Rats in the model control and cell transplantation groups were administered with standard mixed feed, supplemented with 0.1 volume fraction pork fat and high-fat yolk, for 2 months. Streptozotocin was intraperitoneally injected into rats. The type 2 diabetic models were affirmed when the blood glucose level at least 16.77 mmol/L and stabilized for three days. Rats in the normal group were treated with standard mixed feed for 2 months. An equal volume of citrate buffer solution was intraperitoneally injected into rats. Following successful model induction, 0.5 mL (1×106 cells) BMSCs were infused into the tail vein of rats of the cell transplantation group, and rats of other groups were treated with an equal volume of phosphate buffered saline. Main outcome measures: Changes in blood glucose concentration, triacylglycerol and insulin levels, pathological changes in renal tissues; distribution of cells in the kidney and pancreatic tissues. Results: Compared with pretransplantation, no significant difference in blood glucose concentration was detected in the model control group at 7, 14 and 21 days following transplantation, but the blood glucose concentration significantly decreased in the cell transplantation group (P < 0.001). At 21 days following transplantation, compared with the normal group, triacylglycerol levels significantly increased (P < 0.001), but insulin levels significantly reduced (P < 0.001) in the model control and cell transplantation groups. The reduction in insulin levels was lower in the cell transplantation group than in the model control group (P < 0.001). Staining for glycogen results showed that renal glomerulus became hypertrophy in the model control group; renal glomerulus matrix became thinner and hypertrophy was improved in the cell transplantation group. Insulin immunofluorence staining demonstrated that islet cells significantly reduced in the model control group; islet cells increased in the cell transplantation group; BrdU-positive cells were detected in the pancreas and kidney. Conclusion: The transplanted BMSCs can reside at the pancreatic site and renal of type 2 diabetic rats induced by tail vein injection, and can decrease blood glucose and increase insulin secretion.

PET-CT Tracing and Fluorescence Imaging to Monitor the Colonization and Distribution of Combined Transplantation of Islets and BMSC

The Effects of Transplantation of Bone Marrow Mesenchymal Stem Cells and Insulin Producing Cells from Them on Recipient Islets and Neovascularization

Study of Co-Transplantation of Bone Marrow Mesenchymal Cells and Islets for Treating Type 1 Diabetes Mellitus in Sprague-Dawley Rats

The Differentiation of Transplanted Mesenchymal Stem Cells (bmscs)into Pancreas in Diabetic Rat and Its Effect on Blood Glucose Level

Stndy on Diabetic Rat Therapy by Islet Transplantation with Rat Mesenchymal Stem Cells and Scaffold of Pig Small Intestinal Submucosal

Improvement of blood glucose and renal lesions in type 2 diabetic rats following bone marrow mesenchymal stem cell transplantation

Reversal of Hyperglycemia in Diabetic Rats by Portal Vein Transplantation of Islet-Like Cells Generated from Bone Marrow Mesenchymal Stem Cells.

In Vivo Dynamic Metabolic Changes after Transplantation of Induced Pluripotent Stem Cells for Ischemic Injury

Bone Mesenchymal Stem Cells Induced Immunotolerance on Rat to Mouse Islet Transplantation

Mechanism of bone marrow mesenchymal stem cells transplantation in promoting β-cell regeneration in diabetic rats

Effects of different methods of bone mesenchymal stem cell transplantation on recruitment of diabetic rat

[Study of Bone Mesenchymal Stem Cells Tropism for Hepatic Tumors and Effect on the Form of Tumor Stromal].

Pet Demonstrates Functional Recovery after Transplantation of Induced Pluripotent Stem Cells in A Rat Model of Cerebral Ischemic Injury

Longitudinal multimodal monitoring of transplanted islet β-cells

Transplantation of allogeneic pancreatic islets and pancreatic stem cells-derived islet-like structures to treat diabetes

1682-P: Cotransplantation of Islets with Adipose-Derived Stem Cells Synergistically Reduced Blood Glucose in STZ-Induced Diabetic Rats

Tracking transplanted pancreatic islet cells in rats using magnetic resonance imaging

Effect of bone marrow-derived- cells transplantation on islets function of diabetic mice

Co-combination of Islets with Bone Marrow Mesenchymal Stem Cells Promotes Angiogenesis.

Comparison of therapeutic effects of bone marrow mesenchymal stem cell transplantation through pancreas peplos and vein in treatment of diabetes rats

Effects of CTLA4Ig and CD40LIg modified bone marrow mesenchymal stem cells on rejection of rat islet xenografts